Pharma News, 2020

Gedeon Richter Plc.

As drugmakers around the industry look to selloffs, spinoffs and pipeline trims to refocus their operations—and amid challenges from COVID-19—GlaxoSmithKline is planning to start unloading all or ...

ACCORD is a multicentre, seamless, Phase II adaptive randomisation platform trial to assess the efficacy and safety of multiple candidate agents.

Shionogi’s new antibiotic, Fetcroja (cefiderocol), is now approved in Europe for the treatment of infections due to aerobic Gram-negative bacteria in adults with limited treatment options.

(Reuters) - Neurocrine Biosciences Inc said on Monday its add-on treatment for patients with Parkinson’s disease received U.

Regeneron and Sanofi's trial of Kevzara (sarilumab) in hospitalised patients with severe or critical respiratory illness caused by COVID-19 is being amended to include a narrower subset of...

The city of Suzhou in east China's Jiangsu Province aims to build a "Chinese pharma valley" by 2030, according to a biomedical development conference held in the city on Saturday.

The genome of the herpes simplex virus 1 was decoded using new methods.

The World Health Organization (WHO) warned on Saturday that there is no evidence that people who test positive for the new coronavirus are immunised and protected against reinfection.

After President Donald Trump touted the hydroxychloroquine as a potential COVID-19 “game-changer” and the FDA issued an emergency use authorization, the drug regulator is now warning about serious...

AstraZeneca and Merck's Lynparza is already approved in ovarian, breast and pancreatic cancers.

New research finds a connection between destructive white blood cells and a more severe disease course in patients with COVID-19.